Neurocrine Biosciences Total Liabilities and Share Holders Equity 2010-2025 | NBIX

Neurocrine Biosciences total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Neurocrine Biosciences total liabilities and share holders equity for the quarter ending March 31, 2025 was $3.688B, a 6.2% increase year-over-year.
  • Neurocrine Biosciences total liabilities and share holders equity for 2024 was $3.719B, a 14.37% increase from 2023.
  • Neurocrine Biosciences total liabilities and share holders equity for 2023 was $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total liabilities and share holders equity for 2022 was $2.369B, a 14.29% increase from 2021.
Neurocrine Biosciences Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $3,719
2023 $3,251
2022 $2,369
2021 $2,073
2020 $1,735
2019 $1,306
2018 $993
2017 $818
2016 $365
2015 $475
2014 $243
2013 $155
2012 $196
2011 $138
2010 $144
2009 $71
Neurocrine Biosciences Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $3,688
2024-12-31 $3,719
2024-09-30 $3,535
2024-06-30 $3,305
2024-03-31 $3,472
2023-12-31 $3,251
2023-09-30 $2,848
2023-06-30 $2,613
2023-03-31 $2,360
2022-12-31 $2,369
2022-09-30 $2,143
2022-06-30 $2,006
2022-03-31 $2,145
2021-12-31 $2,073
2021-09-30 $2,017
2021-06-30 $1,956
2021-03-31 $1,846
2020-12-31 $1,735
2020-09-30 $1,503
2020-06-30 $1,516
2020-03-31 $1,362
2019-12-31 $1,306
2019-09-30 $1,180
2019-06-30 $1,067
2019-03-31 $958
2018-12-31 $993
2018-09-30 $934
2018-06-30 $841
2018-03-31 $806
2017-12-31 $818
2017-09-30 $772
2017-06-30 $754
2017-03-31 $289
2016-12-31 $365
2016-09-30 $399
2016-06-30 $430
2016-03-31 $459
2015-12-31 $475
2015-09-30 $492
2015-06-30 $511
2015-03-31 $528
2014-12-31 $243
2014-09-30 $258
2014-06-30 $270
2014-03-31 $279
2013-12-31 $155
2013-09-30 $166
2013-06-30 $175
2013-03-31 $184
2012-12-31 $196
2012-09-30 $193
2012-06-30 $202
2012-03-31 $210
2011-12-31 $138
2011-09-30 $149
2011-06-30 $127
2011-03-31 $134
2010-12-31 $144
2010-09-30 $150
2010-06-30 $155
2010-03-31 $80
2009-12-31 $71
2009-09-30 $76
2009-06-30 $87
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.540B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $69.359B 25.88
Takeda Pharmaceutical (TAK) Japan $47.920B 9.53
Daiichi Sankyo, - (DSNKY) Japan $43.494B 22.29
BeOne Medicines - (ONC) Cayman Islands $27.892B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.619B 0.00
Merck (MKKGY) Germany $16.901B 12.38
Summit Therapeutics (SMMT) United States $15.834B 0.00
Shionogi (SGIOY) Japan $14.955B 14.98
United Therapeutics (UTHR) United States $12.814B 11.34
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.882B 64.08
Stevanato Group S.p.A (STVN) Italy $7.598B 46.46
Madrigal Pharmaceuticals (MDGL) United States $6.650B 0.00
Ionis Pharmaceuticals (IONS) United States $6.331B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.037B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.234B 0.00
Hypermarcas (HYPMY) Brazil $2.914B 19.17
Crinetics Pharmaceuticals (CRNX) United States $2.808B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.670B 9.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.071B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.021B 0.00
Indivior (INDV) United States $1.888B 8.01
ARS Pharmaceuticals (SPRY) United States $1.776B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.742B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.339B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Harrow (HROW) United States $1.150B 0.00
Dyne Therapeutics (DYN) United States $1.142B 0.00
Enliven Therapeutics (ELVN) United States $1.056B 0.00
Verve Therapeutics (VERV) United States $1.003B 0.00
Akebia Therapeutics (AKBA) United States $0.982B 0.00
Collegium Pharmaceutical (COLL) United States $0.961B 5.18
Avadel Pharmaceuticals (AVDL) Ireland $0.899B 0.00
Ardelyx (ARDX) United States $0.882B 0.00
Elite Pharmaceuticals (ELTP) United States $0.780B 0.00
Xeris Biopharma Holdings (XERS) United States $0.741B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xencor (XNCR) United States $0.598B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.579B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.50
KalVista Pharmaceuticals (KALV) United States $0.572B 0.00
Relay Therapeutics (RLAY) United States $0.569B 0.00
AleAnna (ANNA) United States $0.550B 0.00
Bioventus (BVS) United States $0.547B 13.88
Theravance Biopharma (TBPH) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.469B 9.79
Organogenesis (ORGO) United States $0.458B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Liminatus Pharma (LIMN) United States $0.432B 0.00
Tourmaline Bio (TRML) United States $0.429B 0.00
Savara (SVRA) United States $0.382B 0.00
Nektar Therapeutics (NKTR) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.06
Heron Therapeutics (HRTX) United States $0.330B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Altimmune (ALT) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.19
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
ProKidney (PROK) United States $0.212B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.206B 0.00
Esperion Therapeutics (ESPR) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.197B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Avita Medical (RCEL) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.100B 16.41
Corbus Pharmaceuticals Holdings (CRBP) United States $0.098B 0.00
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Wellgistics Health (WGRX) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.040B 29.78
ElectroCore (ECOR) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00